These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 6681033)
21. The natural history of salt-wasting disorders of adrenal and renal origin. Rösler A J Clin Endocrinol Metab; 1984 Oct; 59(4):689-700. PubMed ID: 6384251 [TBL] [Abstract][Full Text] [Related]
22. Studies of renin activation and regulation of aldosterone and 18-hydroxycorticosterone biosynthesis in hyporeninemic hypoaldosteronism. Sowers JR; Beck FW; Waters BK; Barrett JD; Welch BG J Clin Endocrinol Metab; 1985 Jul; 61(1):60-7. PubMed ID: 2987296 [TBL] [Abstract][Full Text] [Related]
23. Bromocriptine: lack of effect on the angiotensin II and aldosterone responses to sodium deprivation. Semple PF; Mason PA Clin Endocrinol (Oxf); 1978 Aug; 9(2):155-61. PubMed ID: 699348 [TBL] [Abstract][Full Text] [Related]
24. Increased excretion of 18-hydroxycorticosterone in patients with adrenal adenomas and hypertension. Vecsei P; Abdelhamid S; Haack D; Lichtwald K; Lewicka S; von Mittelstädt G Clin Exp Hypertens A; 1982; 4(9-10):1759-70. PubMed ID: 6291815 [TBL] [Abstract][Full Text] [Related]
25. [The effect of angiotensin I converting enzyme inhibitor (SQ 14225) on plasma 18-hydroxycorticosterone and aldosterone in sodium depleted conscious rats]. Yamamoto I; Iwasaki I; Miyauchi E; Azukizawa S; Kigoshi T; Uchida K; Morimoto S Nihon Naibunpi Gakkai Zasshi; 1990 Jan; 66(1):42-9. PubMed ID: 2407571 [TBL] [Abstract][Full Text] [Related]
26. Dopaminergic modulation of aldosterone secretion in the rhesus monkey: evidence that dopamine affects the late pathway of aldosterone biosynthesis by inhibiting the conversion of corticosterone to 18-hydroxycorticosterone. Sowers JR; Berg G; Martin VS; Mayes DM Endocrinology; 1982 Apr; 110(4):1173-7. PubMed ID: 7060520 [TBL] [Abstract][Full Text] [Related]
27. Lack of enhanced responsiveness of plasma 18-hydroxycorticosterone and aldosterone to adrenocorticotropin as well as to angiotensin-II during moderate sodium depletion in type II diabetic subjects with normoreninemia. Kigoshi T; Iwasaki R; Kaneko M; Nakano S; Azukizawa S; Uchida K; Morimoto S J Clin Endocrinol Metab; 1991 Jun; 72(6):1200-5. PubMed ID: 1851181 [TBL] [Abstract][Full Text] [Related]
28. Altered dopaminergic modulation of 18-hydroxycorticosterone secretion in idiopathic edema: therapeutic effects of bromocriptine. Sowers JR; Beck FW; Berg G J Clin Endocrinol Metab; 1982 Oct; 55(4):749-59. PubMed ID: 7050141 [No Abstract] [Full Text] [Related]
29. Adrenal adenoma with 18-hydroxycorticosterone excess and hypertension: a variant of aldosteronomas. Kigoshi T; Imaizumi N; Azukizawa S; Yamamoto I; Hosojima H; Uchida K; Morimoto S Horm Res; 1984; 19(4):224-31. PubMed ID: 6745843 [TBL] [Abstract][Full Text] [Related]
30. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine. Carey RM; Thorner MO; Ortt EM J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305 [TBL] [Abstract][Full Text] [Related]
31. Evidence of abnormalities in corticosteroid secretion leading to volume-dependent hypertension in Milan rats. Fraser R; Ancil AK; Brown WB; Ingram MC; Holloway CD; Henderson IW; Kenyon CJ Hypertension; 1994 Oct; 24(4):512-5. PubMed ID: 8088920 [TBL] [Abstract][Full Text] [Related]
32. ACTH secretion, circadian variations of salivary free and total serum cortisol and urinary 17-OHCS excretion in active acromegaly following bromocriptine treatment. Ostrowska Z; Zwirska-Korzala K; Buntner B Endocr Regul; 1994 Jun; 28(2):89-95. PubMed ID: 7949021 [TBL] [Abstract][Full Text] [Related]
33. Effect of clonidine on beta-endorphin, ACTH and cortisol secretion in essential hypertension and obesity. Słowinska-Srzednicka J; Zgliczynski S; Soszynski P; Puciłowska J; Wierzbicki M; Jeske W Eur J Clin Pharmacol; 1988; 35(2):115-21. PubMed ID: 2847928 [TBL] [Abstract][Full Text] [Related]
34. Evidence for dopaminergic control of circadian variations in thyrotropin secretion. Sowers JR; Catania RA; Hershman JM J Clin Endocrinol Metab; 1982 Apr; 54(4):673-5. PubMed ID: 7061686 [TBL] [Abstract][Full Text] [Related]
35. Effect of altered sodium intake on circadian rhythm of plasma 18-hydroxycorticosterone in conscious rats. Yamamoto I; Miyauchi E; Yoshida I; Kamei M; Kigoshi T; Hosojima H; Uchida K; Morimoto S Horm Metab Res; 1988 Jun; 20(6):378-9. PubMed ID: 3417222 [No Abstract] [Full Text] [Related]
36. Circadian blood pressure and renin, aldosterone, cortisol, and prolactin levels in hypertensive pseudohypoparathyroid patients. Sowers JR; Brickman AS J Clin Endocrinol Metab; 1982 Dec; 55(6):1202-8. PubMed ID: 6752169 [TBL] [Abstract][Full Text] [Related]
37. Dopaminergic regulation of circadian rhythms of blood pressure, renin and aldosterone in essential hypertension. Sowers JR; Stern N; Nyby MD; Jasberg KA Cardiovasc Res; 1982 Jun; 16(6):317-23. PubMed ID: 7049388 [No Abstract] [Full Text] [Related]
38. Dose-response relationships between plasma adrenocorticotropin (ACTH), cortisol, aldosterone, and 18-hydroxycorticosterone after injection of ACTH-(1-39) or human corticotropin-releasing hormone in man. Oelkers W; Boelke T; Bähr V J Clin Endocrinol Metab; 1988 Jan; 66(1):181-6. PubMed ID: 2826525 [TBL] [Abstract][Full Text] [Related]
39. Circadian rhythm of plasma renin activity in older normal and essential hypertensive men: relation with inactive renin, aldosterone, cortisol and REM sleep. Stern N; Sowers JR; McGinty D; Beahm E; Littner M; Catania R; Eggena P J Hypertens; 1986 Oct; 4(5):543-50. PubMed ID: 3540117 [TBL] [Abstract][Full Text] [Related]
40. Effect of penbutolol on circadian blood pressure, and renin, aldosterone and cortisol levels in patients with essential hypertension. degli Uberti EC; Portaluppi F; Margutti A; Trasforini G; Bianconi M; Teodori V; Rossi R; Pansini R Acta Cardiol; 1988; 43(1):5-20. PubMed ID: 3287810 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]